• Our Services
    • Care Navigation
    • Personalized Action Plans
    • The Cancer Commons Difference
    • Registering with Cancer Commons
    • Enhanced Services
    • Personal Tumor Boards
  • Education
    • Bladder Cancer
    • Brain Cancer
    • Breast Cancer
    • Colorectal Cancer
    • Diffuse Midline Glioma
    • Esophageal Cancer
    • Kidney Cancer
    • Leukemia
    • Liver Cancer
    • Lung Cancer
    • Lymphoma
    • Melanoma
    • Ovarian Cancer
    • Pancreatic Cancer
    • Prostate Cancer
    • Uterine Cancer
  • About Us
    • Our Story
    • Facing Advanced Cancer
    • Meet the Team that Cares
    • Our Core Values
    • Our Partners
    • Support Our Services
    • Talk to Us
    • Financial Documents
  • Testimonials
    • All Testimonials
  • Support Us
    • Donate Now
    • Many Ways to Give
    • What Your Support Makes Possible
  • Our Services
    • Care Navigation
    • Personalized Action Plans
    • The Cancer Commons Difference
    • Registering with Cancer Commons
    • Enhanced Services
    • Personal Tumor Boards
  • Education
    • Bladder Cancer
    • Brain Cancer
    • Breast Cancer
    • Colorectal Cancer
    • Diffuse Midline Glioma
    • Esophageal Cancer
    • Kidney Cancer
    • Leukemia
    • Liver Cancer
    • Lung Cancer
    • Lymphoma
    • Melanoma
    • Ovarian Cancer
    • Pancreatic Cancer
    • Prostate Cancer
    • Uterine Cancer
  • About Us
    • Our Story
    • Facing Advanced Cancer
    • Meet the Team that Cares
    • Our Core Values
    • Our Partners
    • Support Our Services
    • Talk to Us
    • Financial Documents
  • Testimonials
    • All Testimonials
  • Support Us
    • Donate Now
    • Many Ways to Give
    • What Your Support Makes Possible
 

Treatment Options

Learn about the latest treatments for advanced cancer. We’ve got it covered, from new FDA approvals to emerging approaches in immunotherapy, targeted therapy, cancer vaccines, modified viruses, and more.

  • February 3, 2022  

    Kidney Cancer Clinical Trials at UCSF Bookmark

    George Lundberg, MD

    Enrolling in a clinical trial can be great way to access cutting-edge treatments. Here, the University of California, San Francisco, keeps a running list of clinical trials offered there that are currently enrolling people with kidney cancer.

    .

  • February 3, 2022  

    Bladder Cancer Clinical Trials at UCSD Bookmark

    George Lundberg, MD

    Enrolling in a clinical trial can be great way to access cutting-edge treatments. Here, the University of California, San Diego, keeps a running list of clinical trials offered there that are currently enrolling people with bladder cancer.

    .

  • February 3, 2022  

    Transitional Cell Carcinoma Clinical Trials at UCSF Bookmark

    George Lundberg, MD

    Enrolling in a clinical trial can be great way to access cutting-edge treatments. Here, the University of California, San Francisco, keeps a running list of clinical trials offered there that are currently enrolling people with transitional cell carcinoma, the most common form of bladder cancer.

    .

  • January 31, 2022  

    NCCN Guidelines for Patients: Peripheral T-Cell Lymphoma Bookmark

    George Lundberg, MD

    The nonprofit National Comprehensive Cancer Network (NCCN) publishes guidelines for patients to learn more about their diagnosis and their treatment options. Here is their 2022 update for peripheral T-cell lymphoma (PTCL).

    .

  • January 31, 2022  

    NCCN Guidelines for Patients: Acute Myeloid Leukemia Bookmark

    George Lundberg, MD

    The nonprofit National Comprehensive Cancer Network (NCCN) publishes guidelines for patients to learn more about their diagnosis and their treatment options. Here is their 2022 update for acute myeloid leukemia.

    .

  • January 31, 2022  

    NCCN Guidelines for Patients: Small Cell Lung Cancer Bookmark

    George Lundberg, MD

    The nonprofit National Comprehensive Cancer Network (NCCN) publishes guidelines for patients to learn more about their diagnosis and their treatment options. Here is their 2022 update for small cell lung cancer.

    .

  • January 31, 2022  

    NCCN Guidelines for Patients: Cervical Cancer Bookmark

    George Lundberg, MD

    The nonprofit National Comprehensive Cancer Network (NCCN) publishes guidelines for patients to learn more about their diagnosis and their treatment options. Here is their 2022 update for cervical cancer.

    .

  • January 31, 2022  

    NCCN Guidelines for Patients: Kidney Cancer Bookmark

    George Lundberg, MD

    The nonprofit National Comprehensive Cancer Network (NCCN) publishes guidelines for patients to learn more about their diagnosis and their treatment options. Here is their 2022 update for kidney cancer.

    .

  • January 11, 2022  

    Cardiometabolic Medications That Inhibit mTOR Might Help Prevent or Treat Cancer

    With: William H. Bestermann Jr, MD

    Many people believe that cancer is a metabolic disease. A biological process known as the mTOR pathway controls cellular metabolism by way of central signaling, and it is involved in tumor growth. Here, our Curious Dr. George asks William H. Bestermann Jr, MD, an internal medicine doctor, how medications that target the protein mTOR and its associated pathway could prevent or treat cancer. Dr.… Read more »

  • November 22, 2021  

    Using Virtual Trials to Screen for Potential Glioblastoma Therapies

    With: Al Musella, DPM

    The existing drug development system “has failed miserably” for people with glioblastoma brain tumors, according to Al Musella, DPM, President of the Musella Foundation for Brain Tumor Research & Information, Inc. In partnership with Cancer Commons, his organization’s Brain Tumor Virtual Trial aims to speed discovery of promising new glioblastoma treatments. Curious Dr. George: How might your Virtual Trial approach speed the process toward… Read more »

    • «
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • …
    • 25
    • »

You’re not alone. Cancer Commons is a great resource and sounding board to ask questions and get advice and support.

Karen
Advanced breast cancer patient



Cancer Commons is truly unique at rapidly matching patients with advanced cancer with the best precision therapy or clinical trial.

E. David Crawford, MD
Cancer Commons Advisor

Cancer Commons, a patient-centric nonprofit, features compassionate experts who build relationships with advanced cancer patients and caregivers to create personalized action plans. Our nurse navigators, PhD scientists, and national experts consult the latest, most-promising research to identify, explain, and help patients access their best-possible diagnostic and treatment options—so everyone feels confident they’ve left no stone unturned.

Don’t miss Cancer Commons Connects
Exclusive monthly insights and stories—from and for our community

Working.

Dealing with Cancer? Let Us Help

Our Services

  • Care Navigation
  • Personalized Action Plans
  • Registering with Cancer Commons
  • Enhanced Services
  • Personal Tumor Boards
  • Frequently Asked Questions (FAQ)

Perspectives

  • Latest Research
  • Treatment Options
  • Molecular Testing
  • Navigating Treatment
  • Living with Cancer
  • Patient Stories
  • Curious Dr. George
  • The Big Picture
  • Peer-Reviewed Publications

Organization

  • Our Story
  • Our Team
  • Our Core Values
  • Contact Us
  • Board of Directors
  • Partners
  • Expert Physician Advisors

About Us

  • News and Events
  • Contact Us
  • Financial Documents

Support & Giving

  • Contribute Now
  • Many Ways to Give
  • What Your Support Makes Possible
  • Testimonials


Donate

Cancer Commons
650 Castro Street, Suite 120-522
Mountain View, CA 94041, USA
650-289-4044

Patients Hotline

877-971-1200

  • Privacy Policy

© 2023 Cancer Commons.